Neglected parasitic infections in the United States: Cysticercosis

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 5, 2014, Pages 805-809

  Cantey, Paul T ^a   Coyle, Christina M ^b   Sorvillo, Frank J ^d   Wilkins, Patricia P ^a   Starr, Michelle C ^c   Nash, Theodore E ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CORTICOSTEROID; PRAZIQUANTEL;

ANTICONVULSANT THERAPY; ARTICLE; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; ENDEMIC DISEASE; HUMAN; INTRACRANIAL HYPERTENSION; LIFE CYCLE; MICROSURGERY; NEUROCYSTICERCOSIS; PARASITE; PARASITE TRANSMISSION; PARASITOSIS; PROSPECTIVE STUDY; SEIZURE; TAENIA SOLIUM; UNITED STATES;

ANIMALS; FOODBORNE DISEASES; HUMANS; NEUROCYSTICERCOSIS; SEIZURES; SWINE; SWINE DISEASES; TAENIA SOLIUM; UNITED STATES;

EID: 84900455264     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0724     Document Type: Article

References (60)

1. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, Dickey M, Reynolds S, Stoner JA, 2010. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.
2. Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, Tsang VC, Gilman RH, 1999. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29: 1203-1209. (Pubitemid 30265640)
3. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, 1990. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 150: 325-327. (Pubitemid 20063039)
4. Garcia HH, Del Brutto OH, Cysticercosis Working Group in Peru, 2005. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4: 653-661. (Pubitemid 41317300)
5. Wallin MT, Kurtzke JF, 2004. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 63: 1559-1564. (Pubitemid 39507569)
6. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, Pinner RW, Group EMINS, 2002. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8: 608-613. (Pubitemid 34556362)
7. Garcia HH, Gonzalez AE, Evans CA, Gilman RH, Cysticercosis Working Group in Peru, 2003. Taenia solium cysticercosis. Lancet 362: 547-556. (Pubitemid 36976722)
8. Garcia HH, Del Brutto OH, 2003. Imaging findings in neurocysticercosis. Acta Trop 87: 71-78. (Pubitemid 36629485)
9. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M, 2011. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.
10. Garcia HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH, 2005. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 72: 3-9. (Pubitemid 41270299)
11. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proano JV, Takayanagui OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia HH, 2006. Treatment of neurocysticercosis: current status and future research needs. Neurology 67: 1120-1127. (Pubitemid 44563815)
12. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T, 2011. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 9: 123-133.
13. Nash T, 2012. Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health 106: 275-279.
14. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH, Cysticercosis Working Group in Peru, 2008. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 1099-1105.
15. Ooi WW, Wijemanne S, Thomas CB, Quezado M, Brown CR, Nash TE, 2011. Short report: a calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hyg 85: 460-463.
16. Serpa JA, Graviss EA, Kass JS, White AC Jr, 2011. Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore) 90: 81-86.
17. Figueroa JJ, Davis LE, Magalhaes A, 2011. Extraparenchymal neurocysticercosis in Albuquerque, New Mexico. J Neuroimaging 21: 38-43.
18. Cantu C, Barinagarrementeria F, 1996. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 53: 233-239. (Pubitemid 26077475)
19. Callacondo D, Garcia HH, Gonzales I, Escalante D, Nash TE, Cysticercosis Working Group in Peru, 2012. High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology 78: 1394-1400.
20. Lerner A, Shiroishi MS, Zee CS, Law M, Go JL, 2012. Imaging of neurocysticercosis. Neuroimaging Clin N Am 22: 659-676.
21. Feldman M, Plancarte A, Sandoval M, Wilson M, Flisser A, 1990. Comparison of two assays (EIA and EITB) and two samples (saliva and serum) for the diagnosis of neurocysticercosis. Trans R Soc Trop Med Hyg 84: 559-562. (Pubitemid 20266981)
22. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VC, 1991. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164: 1007-1009.
23. Rodriguez S, Wilkins P, Dorny P, 2012. Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health 106: 286-298.
24. Zea-Vera A, Cordova EG, Rodriguez S, Gonzales I, Pretell EJ, Castillo Y, Castro-Suarez S, Gabriel S, Tsang VC, Dorny P, Garcia HH, for the Cysticercosis Working Group in Peru, 2013. Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis 57: e154-e159.
25. Rodriguez S, Dorny P, Tsang VC, Pretell EJ, Brandt J, Lescano AG, Gonzalez AE, Gilman RH, Garcia HH, Cysticercosis Working Group in Peru, 2009. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis 199: 1345-1352.
26. Bustos JA, Rodriguez S, Jimenez JA, Moyano LM, Castillo Y, Ayvar V, Allan JC, Craig PS, Gonzalez AE, Gilman RH, Tsang VC, Garcia HH, Cysticercosis Working Group in Peru, 2012. Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol 19: 570-573.
27. Guezala MC, Rodriguez S, Zamora H, Garcia HH, Gonzalez AE, Tembo A, Allan JC, Craig PS, 2009. Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis. Am J TropMed Hyg 81: 433-437.
28. Allan JC, Wilkins PP, Tsang VC, Craig PS, 2003. Immunodiagnostic tools for taeniasis. Acta Trop 87: 87-93. (Pubitemid 36629487)
29. Nash TE, Mahanty S, Garcia HH, Cysticercosis Group in Peru, 2011. Corticosteroid use in neurocysticercosis. Expert Rev Neurother 11: 1175-1183.
30. Garcia HH, Gonzalez AE, Gilman RH, 2011. Cysticercosis of the central nervous system: how should it be managed? Curr Opin Infect Dis 24: 423-427.
31. Rajshekhar V, 2010. Surgical management of neurocysticercosis. Int J Surg 8: 100-104.
32. Maguire JH, 2004. Tapeworms and seizures-treatment and prevention. N Engl J Med 350: 215-217.
33. Centers for Disease Control and Prevention, 1992. Locally acquired neurocysticercosis-North Carolina, Massachusetts, and South Carolina, 1989-1991. MMWR Morb Mortal Wkly Rep 41: 1-4.
34. Asnis D, Kazakov J, Toronjadze T, Bern C, Garcia HH, McAuliffe I, Bishop H, Lee L, Grossmann R, Garcia MA, Di John D, 2009. Neurocysticercosis in the infant of a pregnant mother with a tapeworm. Am J Trop Med Hyg 81: 449-451.
35. Daniels TL, Moore TA, 2006. Neurocysticercosis in Kansas. Ann Intern Med 144: 150-152.
36. Moore AC, Lutwick LI, Schantz PM, Pilcher JB, Wilson M, Hightower AW, Chapnick EK, Abter EI, Grossman JR, Fried JA, 1995. Seroprevalence of cysticercosis in an Orthodox Jewish community. Am J Trop Med Hyg 53: 439-442.
37. Rosenfeld EA, Byrd SE, Shulman ST, 1996. Neurocysticercosis among children in Chicago. Clin Infect Dis 23: 262-268. (Pubitemid 26264907)
38. McCormick GF, 1985. Cysticercosis: review of 230 patients. Bull Clin Neurosci 50: 76-101.
39. Sorvillo FJ, Waterman SH, Richards FO, Schantz PM, 1992. Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. Am J Trop Med Hyg 47: 365-371.
40. Schantz PM, Moore AC, Munoz JL, Hartman BJ, Schaefer JA, Aron AM, Persaud D, Sarti E, Wilson M, Flisser A, 1992. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 327: 692-695.
41. Barton Behravesh C, Mayberry LF, Bristol JR, Cardenas VM, Mena KD, Martinez-Ocana J, Flisser A, Snowden KF, 2008. Population-based survey of taeniasis along the United States-Mexico border. Ann Trop Med Parasitol 102: 325-333. (Pubitemid 351881275)
42. DeGiorgio C, Pietsch-Escueta S, Tsang V, Corral-Leyva G, Ng L, Medina MT, Astudillo S, Padilla N, Leyva P, Martinez L, Noh J, Levine M, del Villasenor R, Sorvillo F, 2005. Seroprevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurol Scand 111: 84-88. (Pubitemid 40175329)
43. Ciesielski S, Seed JR, Estrada J, Wrenn E, 1993. The seroprevalence of cysticercosis, malaria, and Trypanosoma cruzi among North Carolina migrant farmworkers. Public Health Rep 108: 736-741. (Pubitemid 24015120)
44. Ehnert KL, Roberto RR, Barrett L, Sorvillo FJ, Rutherford GW 3rd, 1992. Cysticercosis: first 12 months of reporting in California. Bull Pan Am Health Organ 26: 165-172.
45. O'Neal S, Noh J, Wilkins P, Keene W, Lambert W, Anderson J, Compton Luman J, Townes J, 2011. Taenia solium tapeworm infection, Oregon, 2006-2009. Emerg Infect Dis 17: 1030-1036.
46. Townes JM, Hoffmann CJ, Kohn MA, 2004. Neurocysticercosis in Oregon, 1995-2000. Emerg Infect Dis 10: 508-510. (Pubitemid 38314483)
47. Croker C, RedelingsM, Reporter R, Sorvillo F,Mascola L, Wilkins P, 2012. The impact of neurocysticercosis in california: a review of hospitalized cases. PLoS Negl Trop Dis 6: e1480.
48. Henneman PL, DeRoos F, Lewis RJ, 1994. Determining the need for admission in patients with new-onset seizures. Ann Emerg Med 24: 1108-1114. (Pubitemid 24368148)
49. del la Garza Y, Graviss EA, Daver NG, Gambarin KJ, Shandera WX, Schantz PM, White AC Jr, 2005. Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg 73: 766-770. (Pubitemid 41446727)
50. Croker C, Reporter R, Mascola L, 2010. Use of statewide hospital discharge data to evaluate the economic burden of neurocysticercosis in Los Angeles County (1991-2008). Am J Trop Med Hyg 83: 106-110.
51. Sorvillo FJ, DeGiorgio C, Waterman SH, 2007. Deaths from cysticercosis, United States. Emerg Infect Dis 13: 230-235. (Pubitemid 46193165)
52. Coyle CM,Mahanty S, Zunt JR,Wallin MT, Cantey PT, White AC Jr, O'Neal SE, Serpa JA, Southern PM, Wilkins P, McCarthy AE, Higgs ES, Nash TE, 2012. Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 6: e1500.
53. Flisser A, Sarti E, Lightowlers M, Schantz P, 2003. Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop 87: 43-51. (Pubitemid 36629483)
54. O'Neal SE, Robbins NM, Townes JM, 2012. Neurocysticercosis among resettled refugees from Burma. J Travel Med 19: 118-121.
55. O'Neal SE, Townes JM, Wilkins PP, Noh JC, Lee D, Rodriguez S, Garcia HH, Stauffer WM, 2012. Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States. Emerg Infect Dis 18: 431-438.
56. Sorvillo F, Wilkins P, Shafir S, Eberhard M, 2011. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 17: 1-6.
57. Richards FO Jr, Schantz PM, Ruiz-Tiben E, Sorvillo FJ, 1985. Cysticercosis in Los Angeles County. JAMA 254: 3444-3448. (Pubitemid 16148409)
58. Del Brutto O, 2012. Neurocysticercosis among international travelers to disease-endemic areas. J Travel Med 19: 112-117.
59. Bobes RJ, Hernandez M, Marquez C, Fragoso G, Garcia E, Parkhouse RM, Harrison LJ, Sciutto E, Fleury A, 2006. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop Med Int Health 11: 943-950. (Pubitemid 43846455)
60. Deckers N, Dorny P, 2010. Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol 26: 137-144.